Threshold Pharmaceuticals (NASDAQ:THLD) is one of today's notable stocks in decline, down 4.6% to $5.21. The S&P is trading lower by 1.5% to 1,605 and the Dow is trading 1.4% lower to 14,906.
Threshold Pharmaceuticals (NASDAQ:THLD) has potential upside of 154.3% based on a current price of $5.21 and analysts' consensus price target of $13.25. The stock should discover initial support at its 50-day moving average (MA) of $5.21 and subsequent support at its 200-day MA of $5.16.
Threshold Pharmaceuticals Inc. is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased cells.
In the past 52 weeks, Threshold Pharmaceuticals share prices have been bracketed by a low of $3.94 and a high of $9.28 and are now at $5.21, 32% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.8% while the 50-day MA has advanced 1.1%.